Veterinary Medicines

Prazpronto 40 mg Spot-on solution for medium cats

Not authorised
  • Praziquantel
Download as PDF

Product identification

Medicine name:
Prazpronto 40 mg Spot-on solution for medium cats
Prazpronto 40 mg Lösung zum Auftropfen für mittelgroße Katzen
Active substance:
  • Praziquantel
Target species:
  • Cat
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Praziquantel
    40.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 1 pipette in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 2 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 3 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 4 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell composed of polypropylene/cyclic olefin copolymer/ethylene vinyl alcohol/polypropylene layer. Carton containing 6 pipettes in individual foil sachets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402725.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0633/002

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download